Z-D-Thr(Bzl)-OH · DCHA is a protected amino acid derivative of threonine in which the amino group is carbobenzyloxy (Z/Cbz) protected and the side-chain hydroxyl is benzyl (Bzl) protected, with the carboxylic acid present as a free acid and the stereochemical designation given as D. The molecule contains a benzylic ester-forming carbamate protecting group on nitrogen, a benzyl ether on the threonine side-chain oxygen, and forms a DCHA salt association that modulates the handling and physicochemical properties of the compound relative to the free base. It is used as a building block for peptide synthesis and for preparing threonine-containing peptide analogues where orthogonal protection of the side-chain hydroxyl supports controlled deprotection and subsequent coupling steps.
CAT No: CP26703
CAS No:201276-12-2
Synonyms/Alias:AKOS024259142;AK-89016;Dicyclohexylamine(2R,3S)-3-(benzyloxy)-2-(((benzyloxy)carbonyl)amino)butanoate;201276-12-2
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.